-

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

  • Sourced from the diabetes community at large through an open call earlier this year, the 16 selected advocates represent strength, advocacy and pride in living with Type 1, Type 2 and prediabetes
  • Dexcom’s World Diabetes Day campaign provides a platform for the selected individuals to advocate for diabetes awareness through their unique, personal stories on a global stage

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom’s World Diabetes Day campaign.

The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person’s experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom’s glucose biosensing technology.

“Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals,” said Maria Alejandra Jove Valerio, one of Dexcom’s new advocates. “What began as a diagnosis at age seven has grown into a lifelong mission to uplift others.”

This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom’s history of and commitment to giving real people with diabetes a platform to share their story on a global stage.

Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate’s personal experience with diabetes, what misconceptions about diabetes they’d like to dispel and how they want to inspire others with diabetes to discover what they’re made of.

To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo* Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day.

Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes.

“Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique and compelling story, but they are all bonded by the shared experience of living with diabetes and passion for helping others in their diabetes journey,” said Lundberg. “I’m looking forward to people around the world seeing the strength of their advocacy shine through in this meaningful campaign.”

Meet the New Dexcom Diabetes Advocates:

  • Ben Schwinof: Portland, OR, United States | Age 50, Type 2 Diabetes
  • Bridget Curran: New York, NY, United States | Age 56, Prediabetes
  • Bruce Moss: Durango, CO, United States | Age 67, Type 1 Diabetes
  • Cindy Reinl: Stuttgart, Germany | Age 26, Type 1 Diabetes
  • Darrell Byers: Boston, United States | Age 64, Type 2 Diabetes
  • Isabelle da Silva: Boca Raton, FL, United States | Age 6, Type 1 Diabetes
  • Jacob Cain: Mesa, AZ, United States | Age 49, Type 2 Diabetes
  • Kari Cichoski: Las Vegas, NV, United States | Age 38, Type 1 Diabetes
  • Kate Beaulieu: Toronto, ON, Canada | Age 20, Type 1 Diabetes
  • Kaye Peterson: Lebanon, KY, United States | Age 68, Type 1 Diabetes
  • Lachie Kennedy: Brisbane, Australia | Age 22, Type 1 Diabetes
  • Maria Alejandra Jove Valerio: Boston, MA, United States | Age 20, Type 1 Diabetes
  • MiYeong Kim: Seoul, South Korea | Age 48, Mother to a Son with Type 1 Diabetes
  • Sofia Pansini: Boston, MA, United States | Age 21, Type 1 Diabetes
  • Tajah Russell: Dallas, TX, United States | Age 31, Type 1 Diabetes
  • Tai'yon Allen Walker: Annapolis, MD, United States | Age 11, Type 1 Diabetes

To learn more about the advocates’ stories, visit Dexcom.com/WorldDiabetesDay or follow Dexcom on Facebook, Instagram or TikTok.

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

*Stelo is cleared by the FDA for adults not on insulin who are 18 older in the United States.

Contacts

Media Contact
Nadia Conard
mediarelations@dexcom.com

Investor Contact
Sean Christensen
sean.christensen@dexcom.com

DexCom, Inc.

NASDAQ:DXCM

Release Versions

Contacts

Media Contact
Nadia Conard
mediarelations@dexcom.com

Investor Contact
Sean Christensen
sean.christensen@dexcom.com

More News From DexCom, Inc.

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically significant reduction in A1C and improvement in glucose control among people with Type 2 diabetes not using insulin compared with a routine care control group using self-monitoring of blood glucose.1 Researchers presented these results today as an oral presentation at the 2026 Scientific Sessions of...

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) will present new clinical findings, product advancements and strategic business initiatives reinforcing its commitment to improving care for people with all types of diabetes and ushering in a new era of early stage CGM intervention and preventative care at the American Diabetes Association’s Scientific Sessions in New Orleans, June 5-8, 2026. “Dexcom has built a legacy of innovation within the diabetes space and as we look to the future, e...

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., the global leader in glucose biosensing, today released its inaugural Customer Advisory Council Report, detailing candid feedback from users, caregivers, healthcare professionals and community leaders, along with clear, actionable company commitments to further elevate product performance and user experience. Building on its position as the manufacturer of the most accurate CGM systems1, Dexcom continues to listen, innovate and act on customer insights...
Back to Newsroom